Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 688505.SS Stock
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Price Chart
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 688505.SS Financial and Trading Overview
Contents
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Price Chart
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 688505.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
- Q&A For Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Stock
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. stock price | 7.14 CNY |
Previous Close | 8.64 CNY |
Open | 8.68 CNY |
Bid | 8.63 CNY x N/A |
Ask | 8.64 CNY x N/A |
Day's Range | 8.61 - 8.75 CNY |
52 Week Range | 7.82 - 11.49 CNY |
Volume | 2.34M CNY |
Avg. Volume | 4.84M CNY |
Market Cap | 6.96B CNY |
Beta (5Y Monthly) | 0.417241 |
PE Ratio (TTM) | 66.38462 |
EPS (TTM) | 0.1 CNY |
Forward Dividend & Yield | 0.07 (0.82%) |
Ex-Dividend Date | July 20, 2022 |
1y Target Est | N/A |
688505.SS Valuation Measures
Enterprise Value | 7.8B CNY |
Trailing P/E | 66.38462 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.446006 |
Price/Book (mrq) | 3.9191647 |
Enterprise Value/Revenue | 7.223 |
Enterprise Value/EBITDA | 47.84 |
Trading Information
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.417241 |
52-Week Change | -14.37% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11.49 CNY |
52 Week Low | 7.82 CNY |
50-Day Moving Average | 9.72 CNY |
200-Day Moving Average | 9.29 CNY |
688505.SS Share Statistics
Avg. Volume (3 month) | 4.84M CNY |
Avg. Daily Volume (10-Days) | 2.79M CNY |
Shares Outstanding | 710.57M |
Float | 455.31M |
Short Ratio | N/A |
% Held by Insiders | 70.93% |
% Held by Institutions | 0.24% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.07 |
Trailing Annual Dividend Yield | 0.81% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.5231 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.14% |
Operating Margin (ttm) | 10.85% |
Gross Margin | 91.38% |
EBITDA Margin | 15.09% |
Management Effectiveness
Return on Assets (ttm) | 2.63% |
Return on Equity (ttm) | 6.34% |
Income Statement
Revenue (ttm) | 1.08B CNY |
Revenue Per Share (ttm) | 1.05 CNY |
Quarterly Revenue Growth (yoy) | 34.30% |
Gross Profit (ttm) | 947.1M CNY |
EBITDA | 162.98M CNY |
Net Income Avi to Common (ttm) | 141.86M CNY |
Diluted EPS (ttm) | 0.13 |
Quarterly Earnings Growth (yoy) | 78.40% |
Balance Sheet
Total Cash (mrq) | 1.08B CNY |
Total Cash Per Share (mrq) | 1.05 CNY |
Total Debt (mrq) | 122.25M CNY |
Total Debt/Equity (mrq) | 5.41 CNY |
Current Ratio (mrq) | 3.435 |
Book Value Per Share (mrq) | 2.202 |
Cash Flow Statement
Operating Cash Flow (ttm) | 22.22M CNY |
Levered Free Cash Flow (ttm) | -57416728 CNY |
Profile of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Country | China |
State | N/A |
City | Shanghai |
Address | Zhangjiang Hi-Tech Park |
ZIP | 201210 |
Phone | 86 21 5895 3355 |
Website | https://www.fd-zj.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 910 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinical trials for triple negative, breast, bladder, gastric, and other tumors; Trop2-BB05 ADC that is in pre-clinical studies for lung cancer and triple negative breast cancer; and HER2 ADC that has completed pre-clinical research for metastatic breast and gastric cancers. The company also provides photodynamic technical platform drugs, such as hemoporfin for port wine stain, which is in Phase IV clinical trial; and aminolevulinic acid, which is in Phase II clinical trials for cervical diseases infected by HPV and acne, as well as completed pre-clinical study for brain gliomas. In addition, it offers nano technical platform drugs, such as Nanoparticle Albumin-bound Paclitaxel that is in pre-clinical studies for tumors, as well as developing Doxorubicin liposome for tumors. Further, the company offers oral solid preparation technology, which includes obeticholic acid for hepatobiliary and autoimmune disease; timolol maleate cream that is in pre-clinical studies for infantile hemangioma; and FZJ-003 oral preparation, which is in Phase I clinical trials for rheumatoid arthritis, as well as in Phase II clinical trials for atopic dermatitis and ulcerative colitis. Additionally, it develops pharmaceutical and medical devices; medical diagnostic products and related services; and sells daily necessities, and clinical laboratory analysis instruments and software. It also engages in the technology development, transfer, consulting, and promotion activities; produces freeze-dried powder injections and APIs; and invests in overseas medical projects. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.
Q&A For Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Stock
What is a current 688505.SS stock price?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 688505.SS stock price today per share is 7.14 CNY.
How to purchase Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. stock?
You can buy 688505.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. is 688505.SS.
Which industry does the Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. company belong to?
The Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. shares is 796.44M.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. PE Ratio is 71.39999400 now.
What was Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. EPS is 0.1 CNY over the trailing 12 months.
Which sector does the Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. company belong to?
The Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. sector is Healthcare.